Skip to main content
Addgene

Enhancer-AAVs allow genetic access to oligodendrocytes and diverse populations of astrocytes across species

Mich JK, Sunil S, Johansen N, Martinez RA, Leytze M, Gore BB, Mahoney JT, Ben-Simon Y, Bishaw Y, Brouner K, Campos J, Canfield R, Casper T, Dee N, Egdorf T, Gary A, Gibson S, Goldy J, Groce EL, Hirschstein D, Loftus L, Lusk N, Malone J, Martin NX, Monet D, Omstead V, Opitz-Araya X, Oster A, Pom CA, Potekhina L, Reding M, Rimorin C, Ruiz A, Sedeño-Cortés AE, Shapovalova NV, Taormina M, Taskin N, Tieu M, Valera Cuevas NJ, Weed N, Way S, Yao Z, McMillen DA, Kunst M, McGraw M, Thyagarajan B, Waters J, Bakken TE, Yao S, Smith KA, Svoboda K, Podgorski K, Kojima Y, Horwitz GD, Zeng H, Daigle TL, Lein ES, Tasic B, Ting JT, Levi BP
bioRxiv 2023.09.20.558718 (Link opens in a new window) Article

Plasmids from Article

ID Plasmid Purpose
214492AiP1421 - pAAV-AiE2119m-minBG-SYFP2-WPRE-BGHpAAiE2119m is an enhancer sequence, designed to drive AAV-mediated transgene expression in specific populations of brain cells
214493AiP1422 - pAAV-AiE2123m-minBG-SYFP2-WPRE-BGHpAAiE2123m is an enhancer sequence, designed to drive AAV-mediated transgene expression in specific populations of brain cells

Antibodies from Article